|Day's Range||28.52 - 29.05|
|52 Week Range||28.06 - 56.44|
|PE Ratio (TTM)||367.44|
|Dividend & Yield||1.36 (4.62%)|
|1y Target Est||N/A|
The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly upward.
Neurocrine may have left the door open for Teva to get an early lead in Tourette's syndrome, an analyst said Wednesday.